Pfizer Seeks to Expand Omicron Booster to 5- to 11-year-olds (VIDEO)
FDA vaccine chief Dr. Peter Marks said last week he expected a decision on boosters for that age group soon.
Stay updated with breaking news from Iontech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
FDA vaccine chief Dr. Peter Marks said last week he expected a decision on boosters for that age group soon.
Pfizer-BioNTech seeks an FDA emergency use approval in the US for children aged 5-11. This booster dose is intended for the original Covid strain, Omicron, and BA.4 and BA.5 subvariants.
PARIS, Sept. 27 (Xinhua) -- France will launch a new vaccination campaign with Omicron-adapted bivalent COVID-19 vaccines next week amid another wave of infecti
NEW YORK CITY (dpa-AFX) - Pfizer Inc. (PFE) and BioNTech SE (BNTX) announced Monday that they have completed a submission to the U.S. Food and Drug Administration requesting Emergency Use Authorization
Updated boosters made by both Pfizer and rival Moderna rolled out earlier this month for everyone 12 and older.